Recent Quotes (30 days)

You have no recent quotes
chg | %

Shire PLC news

   Watch this stock
Showing stories 1 - 10 of about 125   

Articles published

SHP 4,394.00 +22.00 (0.50%)
price chart
Shire PLC Given “Neutral” Rating at Credit Suisse (SHP)
Shire PLC logo Credit Suisse reaffirmed their neutral rating on shares of Shire PLC (LON:SHP) in a research note issued to investors on Wednesday, Marketbeat.
Shire PLC's "Buy" Rating Reiterated at Kepler Capital Markets ...  Financial Wisdom Works
Large Inflow of Money Witnessed in Shire plc
Shares of Shire plc (NASDAQ:SHPG) saw an erosion of -1.21 points in recent session. During the trading, the value of each share was $200.67, dropping -0.6%.
Is It Now Time To Buy Shire plc, Hold AstraZeneca plc & Sell Hikma ...
Shire (LSE: SHP) is bouncing back from its recent lows, but some risk still remains for its shareholders. The same holds true for AstraZeneca (LSE: AZN), yet I do not think that downside risk is any greater for Hikma (LSE: HIK) than for its two larger ...
Biotech Battle: Should You Buy GlaxoSmithKline plc, Shire PLC Or Hikma ...
Hikma Pharmaceuticals (LSE: HIK) and Shire (LSE: SHP) are two of the most exciting biotechs trading on the London market today.
Are Vedanta Resources plc, Shire PLC, Johnson Matthey PLC And Smiths Group plc ...
Shares in Vedanta Resources (LSE: VED) received another hefty whack last week, the business having fallen an extra 13% during the period.
Shire plc (SHPG) Proposes Merger with Baxalta (BXLT)
Shire plc (NASDAQ: SHPG) confirms that it made a proposal to Baxalta Incorporated (NYSE: BXLT) on July 10, 2015, to combine the companies in an all-stock transaction pursuant to which Baxalta shareholders would receive, for each Baxalta share, 0.1687 ...
Shire PLC Bids $30bn For Baxalta  The Motley Fool UK
Could SkyePharma PLC Outperform Shire PLC And Hikma Pharmaceuticals Plc?
Shares in small-cap pharmaceutical firm SkyePharma (LSE: SKP) popped 5% higher this morning, after the firm said that sales had risen by 19% during the first half of 2015 and that underlying trading for 2015 is expected to be “ahead of previous ...
Why I'd Buy Hikma Pharmaceuticals Plc, Hold Shire plc & Sell AstraZeneca plc
Shire is the best of all based on fundamentals, but its stock carries more risk now than at any given time this year. Its latest deal-making ambitions will be debated for months, and Baxalta could be a pricey target - there is a significant risk that ...
Shire PLC's Buy Rating Reaffirmed at Kepler Capital Markets (SHP)
Shire PLC logo Kepler Capital Markets reaffirmed their buy rating on shares of Shire PLC (LON:SHP) in a research note issued to investors on Monday, ARN reports.
Shire PLC Rating Reiterated by Kepler Capital Markets (SHP)  WKRB News
Shire PLC Receives "Buy" Rating from Jefferies Group (SHP)  The Legacy
Shares of Shire plc (NASDAQ:SHPG) Sees Large Inflow of Net Money Flow
Shire plc (NASDAQ:SHPG) dropped -0.82% or -1.67 points to trade at $202.1 per share. As per the latest trading data available, the net money flow stood at $2.88 million as the shares received $44.55 million in upticks and gave away $41.68 million in ...